Randomised phase II trial of oral vinorelbine and cisplatin followed by maintenance with single agent oral vinorelbine versus gemcitabine and cisplatin followed by maintenance with single agent gemcitabine in first line Locally Advanced or Metastati
Randomised phase II trial of oral vinorelbine and cisplatin followed by maintenance with single agent oral vinorelbine versus gemcitabine and cisplatin followed by maintenance with single agent gemcitabine in first line Locally Advanced or Metastati
NAVOTRIAL3
Randomised phase II trial of oral vinorelbine and cisplatin followed by maintenance with single agent oral vinorelbine versus gemcitabine and cisplatin followed by maintenance with single agent gemcitabine in first line Locally Advanced or Metastatic Non-Small-Cell Lung Cancer patients with squamous histological type
Status
Status :
Completed
Type of study
Phase II
Min. Age
18
Years old
Max. Age
-
Gender
All
Therapeutic area :
Oncology
Disease :
Non small cell lung cancer (NSCLC)
Study medication :
Vinorelbine (Navelbine® Oral)
Phase :
Phase II
Start Date :
01 December 2012
End date :
19 May 2017
Study ID :
PM 0259 CA 230 J1
EudraCT/CTIS number :
2012-003531-40
Send by email